Cavitary Mycobacterium avium Complex Lung Disease Developed After Immunotherapy

被引：5
|
作者：
Chi, Chien-Yeh [1 ]
Yeh, Yi-Chen [2 ]
Pan, Sheng-Wei [1 ,3 ]
机构：
[1] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan
[2] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[3] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
来源：
ARCHIVOS DE BRONCONEUMOLOGIA | 2022年 / 58卷 / 02期
关键词：
D O I：
10.1016/j.arbres.2021.04.014
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [31] MYCOBACTERIUM-AVIUM COMPLEX LUNG-DISEASE IN WOMEN
    REICH, JM
    JOHNSON, RE
    CHEST, 1995, 107 (01) : 293 - 294
  • [32] Isolated cavitary pulmonary Mycobacterium avium complex infection in a patient with AIDS
    Alisky, JM
    Schlesinger, L
    CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) : 1542 - 1543
  • [33] Treatment Duration and Disease Recurrence After the Successful Treatment of Patients with Mycobacterium Avium Complex Lung Disease
    Furuuchi, K.
    Morimoto, K.
    Kurashima, A.
    Fujiwara, K.
    Nakamoto, K.
    Tanaka, Y.
    Tachibana, H.
    Yoshimori, K.
    Sasaki, Y.
    Ohta, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [34] The second recurrence of Mycobacterium avium complex lung disease after successful treatment for first recurrence
    Kwon, Byoung Soo
    Shim, Tae Sun
    Jo, Kyung-Wook
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
  • [35] Outcomes and risk factors after adjuvant surgical treatments for Mycobacterium avium complex lung disease
    Yamada, Katsuo
    Seki, Yukio
    Nakagawa, Taku
    Hayashi, Yuta
    Yagi, Mitsuaki
    Ogawa, Kenji
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2019, 67 (04) : 363 - 369
  • [36] Outcomes and risk factors after adjuvant surgical treatments for Mycobacterium avium complex lung disease
    Katsuo Yamada
    Yukio Seki
    Taku Nakagawa
    Yuta Hayashi
    Mitsuaki Yagi
    Kenji Ogawa
    General Thoracic and Cardiovascular Surgery, 2019, 67 : 363 - 369
  • [37] Clinical Outcome with Standard Regimen plus Clofazimine or Moxifloxacin in Cavitary Mycobacterium avium Complex Pulmonary Disease
    Park, Yea Eun
    Chong, Yong Pil
    Lee, Hyun Joo
    Shim, Tae Sun
    Jo, Kyung-Wook
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (12)
  • [38] A 4-DRUG REGIMEN FOR INITIAL TREATMENT OF CAVITARY DISEASE CAUSED BY MYCOBACTERIUM-AVIUM COMPLEX
    AHN, CH
    AHN, SS
    ANDERSON, RA
    MURPHY, DT
    MAMMO, A
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 134 (03): : 438 - 441
  • [39] Giant lamellar bodies in a case of Mycobacterium avium complex lung disease
    Sun, AP
    Ohtsuki, Y
    Fujita, J
    Shigeto, E
    Kohno, N
    PATHOLOGY, 2002, 34 (05) : 473 - 475
  • [40] Factors Associated with Frailty in Patients with Mycobacterium Avium Complex Lung Disease
    Fujita, K.
    Ito, Y.
    Uchida, N.
    Yamamoto, Y.
    Kanai, O.
    Okamura, M.
    Nakatani, K.
    Mio, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
12345